EP
KURA icon

Essential Partners’s Kura Oncology KURA Stock Holding History

Essential Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7K Sell
3,159
-3,407
-52% -$32.1K 0.02% 709
2026
Q1 		$53.4K Sell
6,566
-5,137
-44% -$44.1K 0.02% 585
2025
Q4 		$122K Buy
11,703
+3,539
+43% +$37.1K 0.04% 402
2025
Q3 		$72.3K Buy
8,164
+6,050
+286% +$43.1K 0.02% 511
2025
Q2 		$12.2K Buy
+2,114
New +$13K ﹤0.01% 794

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Essential Partners's KURA Position: Q2 2026 in Review

Essential Partners reduced its Kura Oncology (KURA) stake by 52% in Q2 2026, selling an estimated $32.1K and leaving 3,159 shares worth $34.7K. The position accounts for 0.02% of the portfolio, ranked #709.

Essential Partners first reported a position in KURA in Q2 2025 and has held it in 5 quarters since. The position peaked at $122K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Essential Partners held 3,159 shares of Kura Oncology worth $34.7K as of Q2 2026.
  • Essential Partners sold 3,407 Kura Oncology shares in Q2 2026, an estimated $32.1K.
  • Kura Oncology made up 0.02% of Essential Partners's portfolio in Q2 2026, its #709 holding.
  • Essential Partners first reported a position in Kura Oncology in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Kura Oncology position peaked at $122K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.